Profit and cash flow diverged
Reported profit rose 34.8% but operating cash flow fell 74.8% — worth investigating whether the profit is being collected.
Importance 75 / 95 · cash quality
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
Reported profit rose 34.8% but operating cash flow fell 74.8% — worth investigating whether the profit is being collected.
Importance 75 / 95 · cash quality
Net worth compounded at 34.3% a year over 4 years (₹2,015 → ₹6,549).
Importance 64 / 95 · financial health
Revenue grew 30.5% but only 0.36× of reported profit came through as operating cash.
Importance 62 / 95 · cash quality
ROE of 31.3% is well above the chemicals and petrochemicals median (23.5%), and the P/E of 85.42× is above it too (55.91×).
Importance 60 / 95 · valuation
Classified by the exchange under Commodities › Chemicals › Chemicals & Petrochemicals › Explosives.
Peer set used on this page: 3 chemicals & petrochemicals.
Over 4 years profit compounded at 39.7% a year while revenue compounded at 25.6% a year — though FY2023 saw a one-off step-change of 78% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.
Rule PROFIT_CAGR_VS_REVENUE_CAGR
Revenue compounded at 25.6% a year over 4 years (₹3,948 → ₹9,838) — though FY2023 saw a one-off step-change of 75% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.
Net profit grew 34.8% year on year (FY2025 → FY2026).
Revenue grew 30.5% year on year (FY2025 → FY2026).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q1 FY27 net profit was ₹666 cr, up 89.0% from ₹353 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q1 FY27 revenue was ₹3,668 cr, up 70.3% from ₹2,154 cr in Q1 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q1 FY27 EBIT was ₹944 cr, up 85.8% from ₹508 cr a year earlier.
Rule QTR_OPERATING_PERFORMANCE_CHANGE_YOY
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q2 FY25 | 1,716 | — | 304 | — | 17.7% |
| Q3 FY25 | 1,973 | +38.1% | 338 | +52.1% | 17.1% |
| Q4 FY25 | 2,167 | +34.5% | 346 | +42.6% | 16.0% |
| Q1 FY26 | 2,154 | +27.1% | 353 | +17.3% | 16.4% |
| Q2 FY26 | 2,082 | +21.4% | 362 | +19.1% | 17.4% |
| Q3 FY26 | 2,548 | +29.2% | 467 | +38.2% | 18.3% |
| Q4 FY26 | 3,053 | +40.9% | 556 | +60.7% | 18.2% |
| Q1 FY27 | 3,668 | +70.3% | 666 | +89.0% | 18.2% |
Trailing twelve months to 30 Jun 2026 · sum of the last 4 contiguous quarters
EBITDA margin of 28.0% is the widest in 4 years (prior range 19.1% to 26.9%).
Rule MARGIN_AT_MULTI_YEAR_HIGH
ROE of 31.3% is well above the chemicals and petrochemicals median of 23.5%.
Reported profit rose 34.8% but operating cash flow fell 74.8% — worth investigating whether the profit is being collected.
Rule PROFIT_UP_CASH_DOWN
Net worth compounded at 34.3% a year over 4 years (₹2,015 → ₹6,549).
Revenue grew 30.5% but only 0.36× of reported profit came through as operating cash.
Operating cash flow was only 0.36× reported profit (FY2026).
Free cash flow has been positive in 4 of the last 5 years.
Ranked against 3 chemicals & petrochemicals (FY2026, consolidated).
SOLARINDS · 1st of 3 · set median 11.1%
SOLARINDS · 1st of 3 · set median 25.9%
SOLARINDS · 1st of 3 · set median 23.5%
SOLARINDS · 3rd of 3 · set median 55.9×
ROE of 31.3% is well above the chemicals and petrochemicals median (23.5%), and the P/E of 85.42× is above it too (55.91×).
Rule STRONG_RETURNS_AT_PREMIUM
On the trailing twelve months. Last full year: P/E 100.9× · P/S 17.6× · ROE 31.3%. TTM and full-year profit and EBITDA differ by more than 15% — a one-off in a recent quarter is moving the trailing figure; weigh it against the full year.
Over 4 years the stock returned 58.9% a year while profit compounded at 39.7% a year — but FY2022 profit (₹455) was well below the through-cycle level (~₹875), so this rate is inflated by the recovery from a low base.
Rule STOCK_RAN_AHEAD · recovery
Price-action indicators as of 2026-10-01. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 3,948 | 6,923 | 6,070 | 7,540 | 9,838 |
| Total income | 3,967 | 6,954 | 6,114 | 7,611 | 9,966 |
| EBITDA | 767 | 1,320 | 1,414 | 2,031 | 2,750 |
| Profit before tax | 607 | 1,102 | 1,161 | 1,733 | 2,365 |
| Net profit | 455 | 811 | 875 | 1,288 | 1,737 |
| EPS (₹) | 48.8 | 83.7 | 92.4 | 133.7 | 185.4 |
| Net worth | 2,015 | 2,751 | 3,427 | 4,537 | 6,549 |
| Total debt | 866 | 1,169 | 1,105 | 940 | 1,468 |
| Operating cash flow | 298 | 656 | 1,406 | 2,468 | 621 |
| Free cash flow | 17 | 177 | 858 | 1,462 | −1,072 |
| Ratio | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue growth YoY | — | 75.4 | -12.3 | 24.2 | 30.5 |
| Profit growth YoY | — | 78.1 | 7.9 | 47.2 | 34.8 |
| Profitability | |||||
| EBITDA margin % | 19.4 | 19.1 | 23.3 | 26.9 | 28.0 |
| Net margin % | 11.5 | 11.7 | 14.3 | 16.9 | 17.4 |
| Return on equity % | 22.6 | 34.0 | 28.3 | 32.3 | 31.3 |
| Return on capital % | 22.8 | 35.1 | 30.1 | 37.0 | 37.0 |
| Leverage & cash | |||||
| Debt to equity | 0.43 | 0.43 | 0.32 | 0.21 | 0.22 |
| Cash flow ÷ profit | 0.65 | 0.81 | 1.61 | 1.92 | 0.36 |
| Current ratio | 1.49 | 1.53 | 1.77 | 1.95 | 2.06 |